Tower Research Capital LLC (Trc) Karyopharm Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.87 - $1.58 $29,185 - $53,004
33,547 Added 2049.3%
35,184 $30,000
Q1 2024

May 15, 2024
SELL
$0.72 - $1.66 $7,184 - $16,565
-9,979 Reduced 85.91%
1,637 $2,000
Q4 2023

Feb 13, 2024
SELL
$0.68 - $1.31 $7,159 - $13,791
-10,528 Reduced 47.54%
11,616 $9,000
Q3 2023

Nov 14, 2023
BUY
$1.14 - $1.81 $5,332 - $8,467
4,678 Added 26.78%
22,144 $29,000
Q2 2023

Aug 14, 2023
SELL
$1.79 - $4.59 $3,359 - $8,615
-1,877 Reduced 9.7%
17,466 $31,000
Q1 2023

May 09, 2023
SELL
$2.84 - $3.92 $2,212 - $3,053
-779 Reduced 3.87%
19,343 $75,000
Q4 2022

Feb 10, 2023
SELL
$2.48 - $5.93 $35,402 - $84,650
-14,275 Reduced 41.5%
20,122 $69,000
Q3 2022

Nov 10, 2022
BUY
$4.08 - $5.82 $21,628 - $30,851
5,301 Added 18.22%
34,397 $188,000
Q2 2022

Aug 15, 2022
BUY
$4.15 - $8.37 $93,690 - $188,961
22,576 Added 346.26%
29,096 $131,000
Q1 2022

May 12, 2022
SELL
$5.91 - $14.38 $78,118 - $190,074
-13,218 Reduced 66.97%
6,520 $48,000
Q4 2021

Feb 14, 2022
SELL
$5.21 - $8.61 $32,630 - $53,924
-6,263 Reduced 24.09%
19,738 $127,000
Q3 2021

Nov 15, 2021
BUY
$4.45 - $10.63 $91,776 - $219,233
20,624 Added 383.56%
26,001 $152,000
Q2 2021

Aug 16, 2021
SELL
$8.11 - $11.11 $199,952 - $273,917
-24,655 Reduced 82.1%
5,377 $55,000
Q1 2021

May 17, 2021
SELL
$9.85 - $17.69 $25,629 - $46,029
-2,602 Reduced 7.97%
30,032 $316,000
Q4 2020

Feb 16, 2021
BUY
$14.15 - $17.19 $372,725 - $452,801
26,341 Added 418.58%
32,634 $505,000
Q3 2020

Nov 16, 2020
SELL
$14.14 - $19.71 $85,108 - $118,634
-6,019 Reduced 48.89%
6,293 $92,000
Q2 2020

Aug 13, 2020
BUY
$16.6 - $25.25 $204,379 - $310,878
12,312 New
12,312 $233,000
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $66,795 - $128,759
-4,645 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$9.23 - $19.67 $10,789 - $22,994
1,169 Added 33.63%
4,645 $89,000
Q3 2019

Nov 05, 2019
BUY
$5.66 - $11.85 $16,583 - $34,720
2,930 Added 536.63%
3,476 $34,000
Q2 2019

Aug 13, 2019
SELL
$4.32 - $6.43 $43 - $64
-10 Reduced 1.8%
546 $3,000
Q1 2019

May 14, 2019
BUY
$4.12 - $10.25 $1,466 - $3,649
356 Added 178.0%
556 $3,000
Q4 2018

Feb 14, 2019
SELL
$8.2 - $16.95 $1,574 - $3,254
-192 Reduced 48.98%
200 $2,000
Q3 2018

Nov 13, 2018
SELL
$17.03 - $21.18 $23,739 - $29,524
-1,394 Reduced 78.05%
392 $7,000
Q2 2018

Aug 15, 2018
BUY
$12.0 - $19.88 $21,432 - $35,505
1,786 New
1,786 $30,000
Q1 2018

May 15, 2018
SELL
$9.92 - $17.25 $8,858 - $15,404
-893 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$9.15 - $11.99 $63,080 - $82,659
-6,894 Reduced 88.53%
893 $9,000
Q3 2017

Nov 14, 2017
BUY
$8.15 - $11.16 $63,464 - $86,902
7,787
7,787 $86,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email